2016 No. 6

Cover Content

Previous Issue | Next Issue

Select articles

Display Method:

Editorial

Control of patients' condition and prevention of complications in patients with decompensated liver cirrhosis

Zhong Sheng, Song XinYue, Niu JunQi

2016, 32(6): 1033-1035. DOI: 10.3969/j.issn.1001-5256.2016.06.002

Abstract(2636)

PDF (1544KB)(694) Cited By (7)

Abstract:
Liver cirrhosis is a common digestive disease in China with serious consequences in clinical practice.There are many causes of liver cirrhosis,and in clinical practice,liver cirrhosis is classified into compensated and decompensated liver cirrhosis.Prevention and control of the progression of liver ...

Advances in staging and treatment of hepatitis B cirrhosis

Sun YaMeng, You Hong

2016, 32(6): 1036-1039. DOI: 10.3969/j.issn.1001-5256.2016.06.003

Abstract(3119)

PDF (1560KB)(747) Cited By (35)

Abstract:
Liver cirrhosis is an important stage of the progression of chronic hepatitis B,and it is of great significance to clarify the severity of liver cirrhosis in evaluating prognosis.At present,the clinical staging based on the complications of liver cirrhosis is widely used,but pathological staging sti...

Discussions by experts

Research advances in treatment of cirrhotic ascites

Chen Yu, Zhou Li

2016, 32(6): 1069-1074. DOI: 10.3969/j.issn.1001-5256.2016.06.009

Abstract(2606)

PDF (1583KB)(644) Cited By (53)

Abstract:
Ascites is the most common complication of liver cirrhosis,and prevention and control of the development and progression of ascites are the key to improving the prognosis of patients with liver cirrhosis.This article summarizes the new advances in the treatment of ascites,including the update on fir...

Current research on liver cirrhosis with portal vein thrombosis

Xiong JingPing, Zhang YueXin

2016, 32(6): 1075-1078. DOI: 10.3969/j.issn.1001-5256.2016.06.010

Abstract(2218)

PDF (1561KB)(487) Cited By (4)

Abstract:
Liver cirrhosis is a common cause of portal vein thrombosis(PVT),and the patients with liver cirrhosis complicated by PVT tend to experience complications such as intractable ascites,upper gastrointestinal bleeding,and intestinal necrosis,which may lead to serious consequences and threaten the patie...

Research advances in computed tomography and magnetic resonance imaging findings of cirrhotic portal hypertension

Yan FuHua

2016, 32(6): 1079-1082. DOI: 10.3969/j.issn.1001-5256.2016.06.011

Abstract(2900)

PDF (1565KB)(525) Cited By (26)

Abstract:
Portal hypertension is the most common complication of liver cirrhosis.Noninvasive radiological examinations have important values in evaluating liver parenchyma,collateral circulation,and esophagogastric variceal bleeding in liver cirrhosis.Computed tomography(CT) and magnetic resonance imaging(MRI...

Coagulation disorders in patients with liver cirrhosis

Ning HuiBin, Shang Jia

2016, 32(6): 1083-1085. DOI: 10.3969/j.issn.1001-5256.2016.06.012

Abstract(2413)

PDF (1547KB)(547) Cited By (8)

Abstract:
Liver cirrhosis is a necessary stage of various types of liver diseases progressing into end- stage liver diseases.The changes in coagulation function are still a hot topic in research.The tendency to bleeding and thrombosis is a difficult issue in clinical diagnosis and treatment.This article revie...

Pathological features of liver fibrosis/cirrhosis caused by different factors

Zhou GuangDe, Zhao JingMin

2016, 32(6): 1086-1091. DOI: 10.3969/j.issn.1001-5256.2016.06.013

Abstract(2319)

PDF (1574KB)(516) Cited By (60)

Abstract:
Liver fibrosis / cirrhosis is a pathological process which involves increased deposition of extracellular matrix in liver tissues and changes in liver tissue structure induced by the persistent action of various factors causing liver injury.This article introduces the features of liver fibrosis / ci...

Selection of the diagnostic and therapeutic methods for minimal hepatic encephalopathy

Yan Ming

2016, 32(6): 1092-1099. DOI: 10.3969/j.issn.1001-5256.2016.06.014

Abstract(2293)

PDF (1616KB)(445) Cited By (19)

Abstract:
Currently,since there is still no “gold standard”for the diagnosis of minimal hepatic encephalopathy(MHE),a “quick and simple”diagnosis cannot be made,and a diagnosis needs a comprehensive evaluation.Some new detection techniques,such as imaging examination,have shown their advantages and may become...

Original articles_Liver fibrosis and liver cirrhosis

Current status of malnutrition and its association with prognosis in hospitalized patients with decompensated liver cirrhosis

Zhang HuiKai, Meng XiangLin, Li HaiLei, Xu YuLing, Luo HongWei

2016, 32(6): 1100-1103. DOI: 10.3969/j.issn.1001-5256.2016.06.015

Abstract(2498)

PDF (1570KB)(480) Cited By (39)

Abstract:
Objective To investigate the current status of malnutrition and its association with prognosis in hospitalized patients with decompensated liver cirrhosis.Methods A total of 101 patients with decompensated liver cirrhosis who were treated in our department from January 2013 to December 2014 were enr...

Effect of antiviral therapy on long-term prognosis of patients with decompensated hepatitis B cirrhosis

Yang HanZe

2016, 32(6): 1104-1107. DOI: 10.3969/j.issn.1001-5256.2016.06.016

Abstract(2397)

PDF (1574KB)(405) Cited By (5)

Abstract:
Objective To investigate the effect of antiviral therapy on the long- term prognosis of patients with decompensated hepatitis B cirrhosis.Methods A total of 132 patients with decompensated hepatitis B cirrhosis who were hospitalized in The People's Hospital of Lezhi County 3 times or more from May 2...

Therapeutic effects of entecavir and adefovir dipivoxil in hepatitis B cirrhosis patients with hepatogenous diabetes:a comparative analysis

Li Na, Cui WeiLi, Qiao Bing, Gou Wei

2016, 32(6): 1108-1111. DOI: 10.3969/j.issn.1001-5256.2016.06.017

Abstract(2283)

PDF (1573KB)(506) Cited By (32)

Abstract:
Objective To investigate the therapeutic effect of entecavir or adefovir dipivoxil as the antiviral therapy for hepatitis B cirrhosis patients with hepatogenous diabetes.Methods A total of 80 hepatitis B cirrhosis patients with hepatogenous diabetes who visited Qingdao Hospital of Infectious Disease...

Hepatic myelopathy after transjugular intrahepatic portosystemic shunt:natural course,survival analysis,and treatment

Ren ShuYao, Chen Hui, Lu: Yong, Wang ZhengYu, Niu Jing, Yin ZhanXin, He ChuangYe, Guo WenGang, Han GuoHong

2016, 32(6): 1112-1117. DOI: 10.3969/j.issn.1001-5256.2016.06.018

Abstract(436)

PDF (246KB)(173) Cited By (17)

Abstract:
Objective To investigate the features of hepatic myelopathy(HM) after transjugular intrahepatic portosystemic shunt(TIPS).Methods A retrospective analysis was performed for a consecutive cohort of patients with cirrhotic portal hypertension who were successfully treated with TIPS in Department of Li...

Influence of antiviral therapy with telbivudine on serum soluble complement receptor type 1 in patients with chronic hepatitis B or liver cirrhosis

Wang Fang, Quan ZuoHua, Yang XingKun, Kou JunFeng, Yun ShengHao, Cai GuoFang, Zhou XinRen

2016, 32(6): 1118-1120. DOI: 10.3969/j.issn.1001-5256.2016.06.019

Abstract(1938)

PDF (1562KB)(447) Cited By (1)

Abstract:
Objective To investigate the changes in serum soluble complement receptor type 1(s CR1) at 3 and 6 months after antiviral therapy with telbivudine in patients with chronic hepatitis B(CHB) or liver cirrhosis and the influence of telbivudine on serum s CR1 level.Methods A total of 57 patients with HB...

Changes in natural killer cell frequency,function,and receptor expression in peripheral blood of patients with hepatitis B cirrhosis

Zhang AiMin, Liu FangFang, Yang Xiao, Li WenGang, Han Ping, Duan XueZhang

2016, 32(6): 1121-1124. DOI: 10.3969/j.issn.1001-5256.2016.06.020

Abstract(2020)

PDF (1576KB)(472) Cited By (2)

Abstract:
Objective To investigate the changes in natural killer(NK) cell frequency,function,and receptor expression in the peripheral blood of patients with hepatitis B cirrhosis.Methods A total of 34 patients with hepatitis B cirrhosis who were admitted to 302 Hospital of PLA from June 2013 to December 2014...

Original articles_Viral hepatitis

Simple serum markers for significant liver inflammation in chronic hepatitis B patients with an alanine aminotransferase level lower than 2 times upper limit of normal

Li Qiang, Huang YuXian, Chen Liang

2016, 32(6): 1125-1129. DOI: 10.3969/j.issn.1001-5256.2016.06.021

Abstract(2368)

PDF (237KB)(512) Cited By (8)

Abstract:
Objective To investigate the simple serum markers for significant liver inflammation in chronic hepatitis B(CHB) patients with an alanine aminotransferase(ALT) level of < 2 times upper limit of normal(ULN).Methods The clinical data of 278 CHB patients with ALT < 2 × ULN(ULN = 40 U / L) were an...

Molecular mechanism in the pathogenesis of mild chronic hepatitis B based on microRNA regulation

Zhang ChuanTao, Gu HaiYing, Huang Qun, Liu YeFang, Wang DeLi, Zheng ZhengLong, Hu Rong, Qiao WeiJuan

2016, 32(6): 1130-1134. DOI: 10.3969/j.issn.1001-5256.2016.06.022

Abstract(1730)

PDF (1821KB)(443)

Abstract:
Objective To investigate the molecular mechanism in the pathogenesis of mild chronic hepatitis B from the perspective of microRNA(miRNA) regulation.Methods A total of 16 patients who visited the outpatient service of Chengdu Hospital of Infectious Diseases from July 2013 to February 2014 were enroll...

Original articles_Liver neoplasms

Effect of stereotactic body radiotherapy versus intensity-modulated radiotherapy in primary liver cancer patients with secondary malignant tumor of vertebra

Sun Jing, Po JunJie, Fan YuZe, He WeiPing, Li Huan, Sun YingZhe, Wang Hui, Duan XueZhang

2016, 32(6): 1135-1138. DOI: 10.3969/j.issn.1001-5256.2016.06.023

Abstract(2246)

PDF (1639KB)(406) Cited By (4)

Abstract:
Objective To investigate the effect of stereotactic body radiotherapy(SBRT) versus intensity- modulated radiotherapy(IMRT)in primary liver cancer(PLC) patients with secondary malignant tumor of vertebra.Methods A total of 49 PLC patients with secondary metastatic tumor of vertebra,who were treated i...

Predictive value of neutrophil-lymphocyte ratio and its dynamic change in patients with hepatocellular carcinoma undergoing transarterial chemoembolization

Wang WenJun, Zhao Yan, Xia DongDong, Wang EnXin, Liu Lei, Han GuoHong

2016, 32(6): 1139-1144. DOI: 10.3969/j.issn.1001-5256.2016.06.024

Abstract(2401)

PDF (1816KB)(448) Cited By (15)

Abstract:
Objective To investigate the predictive value of neutrophil- lymphocyte ratio(NLR) and its dynamic change in patients with hepatocellular carcinoma(HCC) undergoing transarterial chemoembolization(TACE).Methods The patients who were diagnosed with HCC and treated with TACE in Xijing Hospital of Diges...

Original articles_Biliary diseases

Clinical application of laparoscopy combined with choledochoscopy and duodenoscopy in treatment of gallstones complicated by intra-and extrahepatic bile duct stones

Wen ZhiQiang, Song Yue, Zhang YaoMing, Xu JiWei, Zhang CaiYun

2016, 32(6): 1145-1148. DOI: 10.3969/j.issn.1001-5256.2016.06.025

Abstract(2085)

PDF (1566KB)(438) Cited By (50)

Abstract:
Objective To summarize the experience in laparoscopy combined with choledochoscopy and duodenoscopy in the treatment of gallstones complicated by intra- and extrahepatic bile duct stones,and to investigate its therapeutic effect.Methods A total of 413 patients with gallstones complicated by intra- a...

Clinical effect of primary duct closure and T-tube drainage after laparoscopic common bile duct exploration:a comparative analysis

Zhang HaiWen, Zhou JianPeng, Wei Feng, Wang GuangYi

2016, 32(6): 1149-1151. DOI: 10.3969/j.issn.1001-5256.2016.06.026

Abstract(2073)

PDF (1790KB)(413) Cited By (22)

Abstract:
Objective To investigate the effect of primary duct closure and T- tube drainage after laparoscopic common bile duct exploration,as well as the criteria for clinical application of primary duct closure.Methods A retrospective analysis was performed for the clinical data of patients with common bile ...

Endoscopic retrograde cholangiopancreatography after Billroth-Ⅱ gastrectomy and its safety

Lei Ting, Nie ZhanGuo, Re HeMan, Liu Ping, You Yun, Jiang LiLi, Zhang Xin

2016, 32(6): 1152-1154. DOI: 10.3969/j.issn.1001-5256.2016.06.027

Abstract(2114)

PDF (1556KB)(448) Cited By (11)

Abstract:
Objective To investigate the safety of endoscopic retrograde cholangiopancreatography(ERCP) after Billroth- Ⅱ gastrectomy.Methods A total of 43 patients who were admitted to our hospital and underwent Billroth-Ⅱ gastrectomy from June 2012 to June 2015 were enrolled and underwent ERCP.Results Of all ...

Brief reports

Ye ChuanTao, Zhao JieRu, Zheng XuYang, Bian PeiYu, Jia ZhanSheng

2016, 32(6): 1165-1166. DOI: 10.3969/j.issn.1001-5256.2016.06.030

Abstract(1678)

PDF (1589KB)(441)

Abstract:

Yi ZhengHui, Chang YingBin

2016, 32(6): 1167-1168. DOI: 10.3969/j.issn.1001-5256.2016.06.031

Abstract(1906)

PDF (1538KB)(441) Cited By (7)

Abstract:

Case reports

Wei HuaFang, Zhou ZhangYu

2016, 32(6): 1169-1170. DOI: 10.3969/j.issn.1001-5256.2016.06.032

Abstract(2042)

PDF (1546KB)(421) Cited By (3)

Abstract:

Yang YiLiang, Cui YuanYuan, Hu Yue, Kong WenLi, Peng ShanShan, Pan Yu

2016, 32(6): 1171-1172. DOI: 10.3969/j.issn.1001-5256.2016.06.033

Abstract(1967)

PDF (221KB)(473) Cited By (2)

Abstract:

A case of tuberculous hepatic abscess secondary to pulmonary tuberculosis

Guo XiangLing, Qi LiNa, Yang Kun, Sun Li, Gao RunPing

2016, 32(6): 1173-1174. DOI: 10.3969/j.issn.1001-5256.2016.06.034

Abstract(2035)

PDF (532KB)(519)

Abstract:

Kang XinDi, Sun Ying, Wen XiaoYu, Niu JunQi, Jin QingLong

2016, 32(6): 1175-1176. DOI: 10.3969/j.issn.1001-5256.2016.06.035

Abstract(2144)

PDF (1598KB)(509) Cited By (6)

Abstract:

Wang CaiMing, Fu ZhaoLiang, Liang ZongChao, Yuan Heng

2016, 32(6): 1177-1178. DOI: 10.3969/j.issn.1001-5256.2016.06.036

Abstract(2075)

PDF (1585KB)(397) Cited By (2)

Abstract:

Chen JiaCheng, Chen XiaoJing, Xiao XiaoLan, Luo HaiMei, Zhou KaiLun

2016, 32(6): 1179-1180. DOI: 10.3969/j.issn.1001-5256.2016.06.037

Abstract(2044)

PDF (1946KB)(404) Cited By (2)

Abstract:

Zhuo HaiYan, Lin Chun, Pan Chen

2016, 32(6): 1181-1182. DOI: 10.3969/j.issn.1001-5256.2016.06.038

Abstract(1491)

PDF (198KB)(428) Cited By (4)

Abstract:

Reviews

New advances in drug therapies for liver fibrosis

Ma ZhenZeng, Lu LunGen

2016, 32(6): 1183-1187. DOI: 10.3969/j.issn.1001-5256.2016.06.039

Abstract(3447)

PDF (1581KB)(746) Cited By (25)

Abstract:
The morbidity and mortality of liver fibrosis induced by a variety of causes remain high around the world and tend to increase year by year.At present,there are no effective radical treatments for liver fibrosis except liver transplantation,and the serious complications of liver fibrosis greatly thr...

Research advances in diagnosis and treatment of spontaneous bacterial peritonitis

Song YuanYuan, Jiang YuYong

2016, 32(6): 1188-1191. DOI: 10.3969/j.issn.1001-5256.2016.06.040

Abstract(2675)

PDF (1577KB)(525) Cited By (43)

Abstract:
Spontaneous bacterial peritonitis(SBP) is a common complication of cirrhotic ascites,and has a high incidence rate,rapid progression,and a high fatality rate.At present,there are no uniform diagnostic criteria for SBP at home and abroad.Some patients do not have the typical clinical symptoms of SBP,...

Research advances in the role of aquaporins in liver fibrosis and liver cirrhosis

Zhang Qiang, Zhao XiangXuan, Sun Wei, Ci DanWangJiu, Guo QiYong

2016, 32(6): 1192-1195. DOI: 10.3969/j.issn.1001-5256.2016.06.041

Abstract(2062)

PDF (1567KB)(441) Cited By (11)

Abstract:
Liver fibrosis is the final outcome of various chronic liver diseases,and various cells,cytokines,and miRNAs are involved in the development and progression of liver fibrosis and liver cirrhosis.Hepatic fibrosis and pathologic angiogenesis are interdependent processes and promote each other,but the ...

Advances in basic research on mesenchymal stem cells and its clinical application in liver cirrhosis

Zhang LiTing

2016, 32(6): 1196-1198. DOI: 10.3969/j.issn.1001-5256.2016.06.042

Abstract(2422)

PDF (1557KB)(435)

Abstract:
Adult mesenchymal stem cells(MSCs) have the features of high plasticity and low immunogenicity,and hold promise for wide clinical application.This article reviews the basic research on MSCs in bone marrow and umbilical cord blood and their clinical application in liver diseases to lay a theoretical ...

Direction and progress in research and development of anti-HBV drugs

Leng XueJun, Zhang Ying, Shen JiaoChun, Yan XueBing

2016, 32(6): 1199-1203. DOI: 10.3969/j.issn.1001-5256.2016.06.043

Abstract(269)

PDF (222KB)(330) Cited By (3)

Abstract:
Chronic hepatitis B(CHB) is considered as the most important risk factor for public health around the world,as well as the main reason for potential diseases to develop into liver cirrhosis and hepatocellular carcinoma.However up to now,there are few methods for the treatment of this lethal viral in...

Association between dynamic changes in HBsAg and progression of chronic hepatitis B

Wang Wei, Rong Jun, Li LiHua, Niu HongYao, Gao HengBo, Zheng HuanWei

2016, 32(6): 1204-1206. DOI: 10.3969/j.issn.1001-5256.2016.06.044

Abstract(2192)

PDF (1556KB)(468) Cited By (5)

Abstract:
With the application of HBs Ag quantification in clinical practice,recent studies have found that HBs Ag level can not only reflect the transcriptional activity of double- stranded covalently closed circular DNA,but also predict the risk of disease progression and response to antiviral therapy in pa...

Research advances in blocking mother-to-child transmission of hepatitis B virus and hepatitis C virus

Zhou LengXiao, Han Tao

2016, 32(6): 1207-1211. DOI: 10.3969/j.issn.1001-5256.2016.06.045

Abstract(1514)

PDF (1577KB)(375) Cited By (8)

Abstract:
Mother- to- child transmission is one of the important routes of hepatitis B virus(HBV) and hepatitis C virus(HCV) infections in China.As for the neonates whose mothers are infected with HBV,a combined injection of hepatitis B vaccine and immunoglobulin is used for vaccination,and about 10% of these...

Basic research and therapeutic strategies for multinodular hepatocellular carcinoma

Yang ZhenYu, Du XiLin, Yang Tao, Tan Kai, He XiaoJun, Chen An

2016, 32(6): 1212-1215. DOI: 10.3969/j.issn.1001-5256.2016.06.046

Abstract(1591)

PDF (1570KB)(410) Cited By (6)

Abstract:
In recent years,with the development of in- depth basic and clinical research on hepatocellular carcinoma(HCC),the heterogeneity,biological characteristics,molecular subtyping,and individualized treatment of HCC have gradually become the basic guiding principles for the clinical treatment of HCC in ...

Current status of research on transcatheter arterial chemoembolization in treatment of colorectal cancer liver metastasis

Jian QianHong, Zheng FangRong, Yan Xiong

2016, 32(6): 1216-1219. DOI: 10.3969/j.issn.1001-5256.2016.06.047

Abstract(1759)

PDF (1567KB)(377) Cited By (10)

Abstract:
It is widely acknowledged that the liver is the most common organ for colorectal cancer metastasis,and radical resection is thought to be the only therapeutic method to cure colorectal cancer liver metastasis(CRLM).Unfortunately,only about 20% of all patients are eligible for surgical resection.In p...

Immunological characteristics of tumor antigen specific T cells and their possible mechanisms in hepatocellular carcinoma

Hou YuLi, Zhang YongHong, Zhao Yan

2016, 32(6): 1220-1224. DOI: 10.3969/j.issn.1001-5256.2016.06.048

Abstract(1412)

PDF (1586KB)(333) Cited By (2)

Abstract:
Hepatocellular carcinoma(HCC) is a major health problem around the world and its morbidity is increasing year by year.HCC has a low rate of early diagnosis and advanced HCC has a low survival rate.Therefore,the diagnosis and treatment of HCC has attracted great attention,and tumor specific T cell im...

Research advances in mechanisms and intervention of hepatic ischemia-reperfusion injury

Wang QingQing, Zhao Xin, Chen YuChao, Dou Jian

2016, 32(6): 1225-1229. DOI: 10.3969/j.issn.1001-5256.2016.06.049

Abstract(1915)

PDF (1587KB)(462) Cited By (45)

Abstract:
Hepatic ischemia- reperfusion injury(HIRI) is a process caused by the combined effect of various factors,and to some extent,it limits the development of liver surgery.In- depth studies on mechanisms of HIRI and the development of reasonable therapeutic strategies have positive effects on the prognos...

Role of follicular helper T cells in development and progression of liver diseases

Ji LongShan, Sun XueHua, Zhou ZhenHua, Zhang Xin, Gao YaTing, Gao YueQiu, Li Man

2016, 32(6): 1230-1234. DOI: 10.3969/j.issn.1001-5256.2016.06.050

Abstract(1643)

PDF (1712KB)(434) Cited By (9)

Abstract:
Follicular helper T cell(TFH) is a new CD4+T lymphocyte subset which helps B lymphocytes to produce antibodies and is closely related to the development and progression of liver diseases.This article reviews the detection and differentiation of TFH and related functional molecules,the mechanism of a...

Expert consensus on enhanced recovery after hepatobiliary & pancreatic surgery(2015 edition)

Chinese Research Hospital Association, Society for Hepatopancreatobiliary Surgery

2016, 32(6): 1040-1045. DOI: 10.3969/j.issn.1001-5256.2016.06.004

Abstract(634)

PDF (256KB)(1465) Cited By (141)

Abstract:

Wang Ran, Qi XingShun, Guo XiaoZhong

2016, 32(6): 1046-1051. DOI: 10.3969/j.issn.1001-5256.2016.06.005

Abstract(217)

PDF (252KB)(138) Cited By (4)

Abstract:

Peng Ying, Qi XingShun, Guo XiaoZhong

2016, 32(6): 1052-1053. DOI: 10.3969/j.issn.1001-5256.2016.06.006

Abstract(214)

PDF (129KB)(254) Cited By (18)

Abstract:

Xia JunXia, Yang QianTing, Liao MingFeng, Zhou BoPing, Yuan Jing

2016, 32(6): 1054-1059. DOI: 10.3969/j.issn.1001-5256.2016.06.007

Abstract(194)

PDF (248KB)(202) Cited By (5)

Abstract:

Shen JiaoChun, Leng XueJun, Zhang Ying, Yan XueBing

2016, 32(6): 1060-1068. DOI: 10.3969/j.issn.1001-5256.2016.06.008

Abstract(2872)

PDF (1634KB)(662) Cited By (7)

Abstract:

Association between non-high-density lipoprotein cholesterol and nonalcoholic fatty liver disease in postmenopausal Uyghur women in Xinjiang,China

Mai LaMuGuLi, 加那尔古丽·夏坎, Cai Wen, Yao Hua

2016, 32(6): 1155-1159. DOI: 10.3969/j.issn.1001-5256.2016.06.028

Abstract(2299)

PDF (1590KB)(460) Cited By (3)

Abstract:
Objective To investigate the association between non- high- density lipoprotein cholesterol(non- HDL- C) and nonalcoholic fatty liver disease(NAFLD) in postmenopausal Uyghur women in Xinjiang,China.Methods A total of 1271 postmenopausal Uyghur women who underwent physical examination in the physical...

Clinical effect of ultrasound-guided injection of lauromacrogol versus anhydrous ethanol as sclerotherapy for simple hepatic cyst:a therapeutic effect analysis and comparative study

Dong JinBin, Shi YiHai, Fang WeiBing

2016, 32(6): 1160-1164. DOI: 10.3969/j.issn.1001-5256.2016.06.029

Abstract(459)

PDF (221KB)(323) Cited By (30)

Abstract:
Objective To investigate the clinical effect of ultrasound- guided injection of lauromacrogol versus anhydrous ethanol as the sclerotherapy for simple hepatic cyst,as well as the incidence rates of adverse events and changes in liver function and the results of routine blood test after surgery,and t...